FI20060246A0 - Uusi kasvua stimuloiva proteiini ja sen käyttö - Google Patents

Uusi kasvua stimuloiva proteiini ja sen käyttö

Info

Publication number
FI20060246A0
FI20060246A0 FI20060246A FI20060246A FI20060246A0 FI 20060246 A0 FI20060246 A0 FI 20060246A0 FI 20060246 A FI20060246 A FI 20060246A FI 20060246 A FI20060246 A FI 20060246A FI 20060246 A0 FI20060246 A0 FI 20060246A0
Authority
FI
Finland
Prior art keywords
stimulating protein
growth
preventing
new growth
growth stimulating
Prior art date
Application number
FI20060246A
Other languages
English (en)
Swedish (sv)
Inventor
Jukka Westermarck
Pietri Puustinen
Melissa Junttila
Original Assignee
Jukka Westermarck
Pietri Puustinen
Melissa Junttila
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jukka Westermarck, Pietri Puustinen, Melissa Junttila filed Critical Jukka Westermarck
Priority to FI20060246A priority Critical patent/FI20060246A0/fi
Publication of FI20060246A0 publication Critical patent/FI20060246A0/fi
Priority to CA002646898A priority patent/CA2646898A1/en
Priority to AT07730631T priority patent/ATE485047T1/de
Priority to PCT/FI2007/050137 priority patent/WO2007104835A1/en
Priority to DK10168717.6T priority patent/DK2229946T3/da
Priority to US12/225,114 priority patent/US20090232821A1/en
Priority to CN2007800170373A priority patent/CN101443022B/zh
Priority to EP07730631A priority patent/EP2004202B1/en
Priority to EP10168717.6A priority patent/EP2229946B1/en
Priority to JP2008558839A priority patent/JP5139332B2/ja
Priority to DE602007009950T priority patent/DE602007009950D1/de
Priority to ES10168717T priority patent/ES2429131T3/es
Priority to US13/246,696 priority patent/US8410072B2/en
Priority to US13/849,210 priority patent/US9062309B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4706—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
FI20060246A 2006-03-16 2006-03-16 Uusi kasvua stimuloiva proteiini ja sen käyttö FI20060246A0 (fi)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FI20060246A FI20060246A0 (fi) 2006-03-16 2006-03-16 Uusi kasvua stimuloiva proteiini ja sen käyttö
ES10168717T ES2429131T3 (es) 2006-03-16 2007-03-14 Uso de la proteína estimulante del crecimiento KIAA1524
CN2007800170373A CN101443022B (zh) 2006-03-16 2007-03-14 生长刺激蛋白质的用途
AT07730631T ATE485047T1 (de) 2006-03-16 2007-03-14 Verwendung eines wachstumsstimulierenden proteins
PCT/FI2007/050137 WO2007104835A1 (en) 2006-03-16 2007-03-14 Use of a growth-stimulating protein
DK10168717.6T DK2229946T3 (da) 2006-03-16 2007-03-14 Anvendelse af vækst-stimulerende protein KIAA1524
US12/225,114 US20090232821A1 (en) 2006-03-16 2007-03-14 Use Of A Growth-Stimulating Protein
CA002646898A CA2646898A1 (en) 2006-03-16 2007-03-14 Use of a growth-stimulating protein
EP07730631A EP2004202B1 (en) 2006-03-16 2007-03-14 Use of a growth-stimulating protein
EP10168717.6A EP2229946B1 (en) 2006-03-16 2007-03-14 Use of the growth-stimulating protein KIAA1524
JP2008558839A JP5139332B2 (ja) 2006-03-16 2007-03-14 成長刺激タンパク質の使用
DE602007009950T DE602007009950D1 (de) 2006-03-16 2007-03-14 Verwendung eines wachstumsstimulierenden proteins
US13/246,696 US8410072B2 (en) 2006-03-16 2011-09-27 Use of a growth-stimulating protein
US13/849,210 US9062309B2 (en) 2006-03-16 2013-03-22 Use of a growth-stimulating protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20060246A FI20060246A0 (fi) 2006-03-16 2006-03-16 Uusi kasvua stimuloiva proteiini ja sen käyttö

Publications (1)

Publication Number Publication Date
FI20060246A0 true FI20060246A0 (fi) 2006-03-16

Family

ID=36191923

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20060246A FI20060246A0 (fi) 2006-03-16 2006-03-16 Uusi kasvua stimuloiva proteiini ja sen käyttö

Country Status (11)

Country Link
US (3) US20090232821A1 (fi)
EP (2) EP2229946B1 (fi)
JP (1) JP5139332B2 (fi)
CN (1) CN101443022B (fi)
AT (1) ATE485047T1 (fi)
CA (1) CA2646898A1 (fi)
DE (1) DE602007009950D1 (fi)
DK (1) DK2229946T3 (fi)
ES (1) ES2429131T3 (fi)
FI (1) FI20060246A0 (fi)
WO (1) WO2007104835A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20060246A0 (fi) * 2006-03-16 2006-03-16 Jukka Westermarck Uusi kasvua stimuloiva proteiini ja sen käyttö
US20100047830A1 (en) * 2007-02-01 2010-02-25 University Of Florida Research Foundation, Inc. Compositions and methods for detecting cancers in a subject
CN101664550A (zh) * 2008-09-07 2010-03-10 苏州爱生基因有限公司 治疗或预防癌症的方法和药物
FI20115876A0 (fi) 2011-09-06 2011-09-06 Turun Yliopisto Yhdistelmähoito
CN103484463A (zh) * 2013-09-12 2014-01-01 四川大学 一种沉默人c2orf68基因的shRNA及其医药用途
WO2016203118A1 (en) * 2015-06-18 2016-12-22 Turun Yliopisto Crystal structures of cip2a
DK3714070T3 (da) * 2017-11-20 2022-02-07 Turun Yliopisto Hidtil ukendt cip2a-variant og anvendelser deraf
CN111549033B (zh) * 2020-06-11 2021-02-12 南京市江宁医院 慢病毒感染人表皮角质细胞株及其构建方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002081628A2 (en) 2001-04-05 2002-10-17 Ribozyme Pharmaceuticals, Incorporated Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
PT1309726E (pt) * 2000-03-30 2010-03-08 Whitehead Biomedical Inst Mediadores de interferência por rna específicos de sequência de rna
US20030190635A1 (en) 2002-02-20 2003-10-09 Mcswiggen James A. RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
DK2813582T3 (en) * 2000-12-01 2017-07-31 Max-Planck-Gesellschaft Zur Förderung Der Wss E V Small RNA molecules that mediate RNA interference
US6743619B1 (en) * 2001-01-30 2004-06-01 Nuvelo Nucleic acids and polypeptides
US20040019001A1 (en) 2002-02-20 2004-01-29 Mcswiggen James A. RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA
US20030175950A1 (en) 2001-05-29 2003-09-18 Mcswiggen James A. RNA interference mediated inhibition of HIV gene expression using short interfering RNA
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
US20050008617A1 (en) 2002-09-28 2005-01-13 Massachusetts Institute Of Technology Compositions and methods for delivery of short interfering RNA and short hairpin RNA
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
CA2528669A1 (en) * 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US20050043266A1 (en) 2003-07-25 2005-02-24 Sumedha Jayasena Short interfering RNA as an antiviral agent for hepatitis C
WO2005116204A1 (ja) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Ｒｎａ干渉を生じさせるポリヌクレオチド、および、これを用いた遺伝子発現抑制方法
FI20060246A0 (fi) * 2006-03-16 2006-03-16 Jukka Westermarck Uusi kasvua stimuloiva proteiini ja sen käyttö

Also Published As

Publication number Publication date
DK2229946T3 (da) 2013-10-14
DE602007009950D1 (de) 2010-12-02
US20120077750A1 (en) 2012-03-29
CN101443022A (zh) 2009-05-27
EP2229946A3 (en) 2011-01-19
EP2229946B1 (en) 2013-08-14
US9062309B2 (en) 2015-06-23
EP2004202A1 (en) 2008-12-24
JP2009530593A (ja) 2009-08-27
ATE485047T1 (de) 2010-11-15
CA2646898A1 (en) 2007-09-20
EP2004202B1 (en) 2010-10-20
CN101443022B (zh) 2012-05-30
ES2429131T3 (es) 2013-11-13
EP2229946A2 (en) 2010-09-22
US20090232821A1 (en) 2009-09-17
EP2004202A4 (en) 2009-11-11
WO2007104835A1 (en) 2007-09-20
JP5139332B2 (ja) 2013-02-06
US20130197063A1 (en) 2013-08-01
US8410072B2 (en) 2013-04-02

Similar Documents

Publication Publication Date Title
FI20060246A0 (fi) Uusi kasvua stimuloiva proteiini ja sen käyttö
MX2008006076A (es) Metodos, composiciones y kits para el tratamiento de condiciones medicas.
ATE552000T1 (de) Verwendung von isothiocyanat-verbindungen zur behandlung von prostata-erkrankungen und hautkrebs
DE602006016760D1 (de) Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen
MY156811A (en) Use of dithiine-tetracarboximides for controlling phytopathogenic fungsi
ATE473630T1 (de) Verfahren zur bekämpfung von pflanzenkrankheitsschäden durch verwendung eines bacillus
TW200738270A (en) Method of treating depression using a TNFα antibody
NZ590550A (en) Inhibitors of Apoptosis (IAP) for treating cancer
GT200500213A (es) Composiciones fungicidas
ATE447559T1 (de) 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3- carboxamid derivate als mek inhibitoren zur behandlung von hyperproliferativen erkrankungen
SG151309A1 (en) Novel use of peptide compounds for treating pain in painful diabetic neuropathy
ATE429645T1 (de) Verwendung von eph-rezeptor-inhibitoren zur behandlung neurodegenerativer krankheiten
ATE449771T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
TW200714283A (en) Method and composition for treating peripheral vascular diseases
DE502006000198D1 (de) Verfahren zum Steuern und/oder Regeln von landwirtschaftlichen Schleuderdüngerstreuern
EA201190072A1 (ru) Способы регулирования деполимеризации полимерных композиций
ATE452131T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
ATE495170T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
ATE496912T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
TW200716132A (en) Novel chemical compounds
UA102221C2 (ru) Композиция для улучшения жизнеспособности растения
HK1105771A1 (en) Method of treating microbial plant diseases
ATE443991T1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit

Legal Events

Date Code Title Description
FD Application lapsed